Home » Topics » Nephrology, BioWorld Science

Nephrology, BioWorld Science
RSS

Phase II trial of AQX-1125 in interstitial cystitis/bladder pain syndrome is under way

July 8, 2013

Vivus obtains European approval for avanafil

June 27, 2013

Mesoblast receives approval for trial of mesenchymal precursor cells

June 27, 2013

Anthera Pharmaceuticals begins phase II BRIGHT-SC study in IgA nephropathy

June 26, 2013

Vivus study shows avanafil is effective for sexual activity within 15 minutes

June 21, 2013

Chinese researchers patent novel alpha1A-adrenoceptor antagonists

June 19, 2013

Natural derived polymer VS-501 may control serum phosphate in CKD

June 13, 2013

Vitaros approved in Europe for erectile dysfunction

June 12, 2013

PBI-4050 demonstrates promising antifibrotic properties in vivo

June 11, 2013

La Jolla Pharmaceutical submits IND to the FDA for LJPC-501

June 5, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...
GABA signaling linked to immune resistance in some tumors
BioWorld
Certain cancers that contain organized clusters of immune cells known as tertiary lymphoid structures (TLS) do not respond to treatment as well as expected. Even...